Technology
Health
Biotechnology
Prothena
$12.309876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$12.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.00 (-7.52%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Prothena and other stocks, options, ETFs, and crypto commission-free!
About
Prothena Corporation plc Ordinary Shares, also called Prothena, is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. Read More The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Employees
59
Headquarters
Dun Laoghaire, Dublin
Founded
1969
Market Cap
490.32M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
600.29K
High Today
$13.28
Low Today
$12.25
Open Price
$13.23
Volume
148.93K
52 Week High
$44.75
52 Week Low
$8.63
Collections
Technology
Health
Biotechnology
Medical
Europe (Non-UK)
Europe
News
Price Paid on Robinhood
34% Lower
Right Now
52 Week Low
$8.63
Average Price Paid
$18.62
52 Week High
$44.75
Earnings
-$1.48
-$1.14
-$0.80
-$0.46
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 7, After Hours